Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. A. Tsatsurova"'
Autor:
E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 4, Pp 385-392 (2022)
Aim. To assess the structure and performance of left atrium (LA) before and after 3 cycles of anticancer treatment in lymphoma patients, as well as the incidences of supraventricular arrhythmia (SVA) and the levels of biomarkers of inflammation.Mater
Externí odkaz:
https://doaj.org/article/9240aeffbbdc46338439833b544c3365
Autor:
A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 476-483 (2021)
Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago. It's accepted that HFpEF is
Externí odkaz:
https://doaj.org/article/c7ce94c4d13c4fb0b9597a86d8501960
Autor:
E. Yu. Salakheeva, A. A. Shchendrygina, I. Ya. Sokolova, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, Yu. N. Muzychenko, S. A. Kardanova, V. O. Stebakova, E. V. Privalova, T. Yu. Kulagina, O. A. Bulkina, I. S. Ilgisonis, Yu. N. Belenkov
Publikováno v:
Clinical Medicine (Russian Journal). 101:55-62
Aim. To assess the dynamics of functional changes in the left atrium (LA) in patients with lymphoproliferative diseases (LPD) before polychemotherapy (PCT), during treatment, after 6 courses of treatment, and the frequency of supraventricular arrhyth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbfbe0e4189f3de8a38bee74e4d78f83
https://doi.org/10.30629/0023-2149-2023-101-1-55-62
https://doi.org/10.30629/0023-2149-2023-101-1-55-62
Autor:
Yu A Danilogorskaya, Yu N Belenkov, I. Ya. Sokolova, E. Yu. Salakheeva, S. A. Tsatsurova, A A Shchendrygina, A. A. Ageeva, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 3, Pp 476-483 (2021)
Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago. It's accepted that HFpEF is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a437227612ae7820537df786f1db790b
https://doi.org/10.20996/1819-6446-2021-05-01
https://doi.org/10.20996/1819-6446-2021-05-01